Hope on the Horizon: Africa Nears Mpox Downgrade as Seven Nations Hit ‘End Phase’ Milestone
Addis Ababa, Ethiopia – In a beacon of progress amid ongoing global health vigilance, the Africa Centres for Disease Control and Prevention (Africa CDC) announced Thursday that the continent is on the cusp of downgrading Mpox from its status as a Public Health Emergency of Continental Security, with seven countries now firmly in the “end phase” and more poised to follow. This shift signals a dramatic turnaround from the virus’s explosive spread earlier in 2025, offering relief to communities battered by outbreaks.
Mpox, formerly known as monkeypox, erupted across sub-Saharan Africa in early 2025, primarily driven by the more transmissible clade Ib variant originating in the Democratic Republic of Congo (DRC). What began as isolated zoonotic spillovers from rodents quickly escalated into sustained human-to-human transmission, fueled by close-contact scenarios in crowded urban settings and conflict zones. By mid-year, the WHO had declared it a global emergency, reporting over 40,000 cases in the DRC alone, alongside surges in neighboring Burundi, Uganda, and beyond. Symptoms—fever, swollen lymph nodes, and distinctive pus-filled lesions—struck hardest among children, pregnant women, and those with weakened immune systems like HIV patients, claiming hundreds of lives with a fatality rate hovering around 3%.
Fast-forward to December 2025: Weekly confirmed cases have plummeted 52% continent-wide, thanks to ramped-up vaccination drives, contact tracing, and community education. Yap Boum, Africa CDC’s Incident Manager for Health Emergencies, highlighted this during a virtual press briefing on December 11. “At the continental level, we expect more than 45 days with no cases before a country is classified as being in the control phase,” Boum stated. Seven nations—though specifics weren’t named in the briefing—have already achieved this, maintaining zero infections for extended stretches. Sierra Leone is next, slated to enter the control phase on December 16 after surpassing 42 case-free days. Once a critical mass sustains this, the downgrade could follow swiftly.
This isn’t guesswork; Africa CDC’s decision hinges on five rigorous criteria: no sustained human-to-human transmission, shrinking regional risks, robust surveillance systems, rapid response capabilities, and declining epidemiological trends. While population displacements from DRC’s Uvira region into Burundi sparked brief alarms over potential spillover, officials deem the threat minimal, with no uptick in cases tied to these movements.
Experts are cautiously optimistic. “This marks a pivotal moment in Africa’s fight against Mpox, proving that targeted interventions work,” says Dr. Amina Jibril, a virologist at the University of Lagos, who consulted on regional vaccine distribution. “We’ve vaccinated over a million in high-risk zones, but equity remains key—urban-rural gaps in access could reignite sparks.” Public reactions mirror this blend of hope and wariness; on X, users from affected countries shared relief with posts like “Finally, light at the end of the outbreak tunnel! #MpoxEndPhase,” while others urged sustained funding, noting, “Downgrade yes, but don’t drop the ball—kids in DRC still need shots.” Health advocates, including the African Union, echoed calls for stronger cross-border coordination to prevent resurgence.
For U.S. readers, this development carries direct ripples in public health and economics. With over 100 imported Mpox cases linked to travel from Africa since January 2025—mostly clade Ib detections in states like New York and California—the downgrade eases pressures on the CDC’s surveillance networks and border screenings. Economically, it stabilizes global supply chains disrupted by quarantines in African mining hubs, benefiting U.S. firms reliant on Congolese cobalt for EV batteries, a sector projected to add $50 billion to American GDP by 2030. Technologically, it spotlights U.S.-donated tools like rapid PCR kits, which amplified detection rates by 40% in partner nations, fostering goodwill amid Biden-era Africa initiatives. Lifestyle-wise, frequent flyers and diaspora communities—Nigerian-Americans alone number 400,000—can breathe easier, though experts recommend Jynneos vaccinations for high-risk travelers.
User intent here leans toward reassurance and practical advice: Families and travelers want to know if it’s safe to visit or host relatives from outbreak zones. The answer? Yes, with precautions—avoid close contact in endemic areas, monitor for symptoms up to 21 days post-travel, and consult the CDC app for real-time alerts. For management, health officials advise integrating Mpox surveillance into routine STI clinics, given overlaps with HIV hotspots, and stockpiling antivirals like tecovirimat for vulnerable groups.
Contextually, this builds on the WHO’s September 2025 lift of its global emergency status, after cases dipped in hotspots like DRC and Uganda. Yet Africa CDC held firm on continental measures, prioritizing local data over international benchmarks. Vaccination lags persist—only 3 million doses administered versus a 20-million need—but pledges from Gavi and Moderna are bridging gaps, with mRNA trials showing 90% efficacy against clade Ib.
As more nations like Sierra Leone tip into control, the downgrade isn’t just procedural; it’s a testament to resilient health systems forged in crisis. Flare-ups remain possible, especially with holiday travel peaking, but the trajectory points to containment.
In summary, with seven countries in the end phase and declining cases across Africa, Mpox’s continental downgrade is imminent, slashing emergency strains while underscoring the need for vigilant, funded responses. The future outlook? A transition to endemic management by mid-2026, potentially averting billions in healthcare costs and paving the way for similar wins against other zoonotics.
By Sam Michael
Follow us on X @realnewshubs and subscribe for push notifications to stay locked on every US judge orders Kilmar Abrego Garcia’s release from ICE custody development!
Follow and subscribe to us for more updates and push notifications.